Study of Product of Conception Derived From Ultrasound-guided Manual Vacuum Aspiration

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18+
SponsorChinese University of Hong Kong

About this trial

Early pregnancy loss is very common, approximately one in four women will experience a miscarriage in their lifetime. The etiology of pregnancy loss remains largely unknown, although genetic, anatomical, endocrinological and immunological abnormalities have been implicated.

It is known that embryonic/fetal chromosomal aberrations contributed to approximately 50% of early pregnancy loss, among which 60-70% were aneuploidies, largely can be detected by the current gold standard karyotyping approach recommended by various international societies. However, the drawbacks of conventional karyotyping include the risk of culture failure, maternal cell contamination (MCC), limited detection resolution (5-10 Mb), and differential growth of specific cell lineages which could hinder the diagnosis of genetic abnormalities, particularly mosaicisms. Additional genetic factors beyond the resolution of karyotyping are not well studied.

Eligibility criteria

Qualifiers

Women 18 years old or above

Women with miscarriage or TOP who are suitable candidates for MVA

first trimester miscarriage or TOP

No fetal heart beat or TOP in those with CRL 25mm

Disqualifiers

Women who are not feasible for the MVA procedure

cervical stenosis

fibroid uterus >12 weeks in size

known uterine malformation

Trial design

Treatments tested in this trial

  • Ultrasound-guided manual vaccum

Treatment groups

No treatment groups listed